Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis

FASEB Journal

Volumn 27, Issue 4, 2013, Pages 1674-1689

  Corbin, Karen D ^a,b   Abdelmalek, Manal F ^d   Spencer, Melanie D ^a,c   Da Costa, Kerry Ann ^a   Galanko, Joseph A ^b   Sha, Wei ^f   Suzuki, Ayako ^d   Guy, Cynthia D ^e   Cardona, Diana M ^e   Torquati, Alfonso ^e   Diehl, Anna Mae ^d   Zeisel, Steven H ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b University School of Public Health   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DUKE UNIVERSITY   (United States)

^f University of North Carolina at Charlotte   (United States)

Author keywords

Metabolic syndrome; Nonalcoholic fatty liver disease; Nutrition; Obesity; Single nucleotide polymorphisms

Indexed keywords

CHOLINE;

ADULT; ARTICLE; CARBON METABOLISM; CONTROLLED STUDY; DISEASE SEVERITY; ETHNICITY; FATTY LIVER; FEMALE; GENE; GENE CLUSTER; GENETIC PARAMETERS; GENETIC SIGNATURE; GENETIC SUSCEPTIBILITY; HUMAN; LIVER BIOPSY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; PREDICTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARBON; CHOLINE; FATTY LIVER; GENOTYPE; HUMANS; LIVER; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84875714410     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-219097     Document Type: Article

References (56)

1. Ong, J. P., and Younossi, Z. M. (2007) Epidemiology and natural history of NAFLD and NASH. Clin. Liver Dis. 11, 1-16, vii.
2. Hooper, A. J., Adams, L. A., and Burnett, J. R. (2011) Genetic determinants of hepatic steatosis in man. J. Lipid Res. 52, 593-617.
3. Siddique, A., and Kowdley, K. V. (2011) Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma. Clin. Liver Dis. 15, 281-296, vii-x.
4. Corbin, K. D., and Zeisel, S. H. (2011) Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr. Opin. Gastroenterol. 28, 159-165, 2012.
5. Noga, A. A., Zhao, Y., and Vance, D. E. (2002) An unexpected requirement for phosphatidylethanolamine N-methyltransferase in the secretion of very low density lipoproteins. J. Biol. Chem. 277, 42358-42365.
6. Fischer, L. M., daCosta, K. A., Kwock, L., Stewart, P. W., Lu, T. S., Stabler, S. P., Allen, R. H., and Zeisel, S. H. (2007) Sex and menopausal status influence human dietary requirements for the nutrient choline. Am. J. Clin. Nutr. 85, 1275-1285.
7. Da Costa, K. A., Kozyreva, O. G., Song, J., Galanko, J. A., Fischer, L. M., and Zeisel, S. H. (2006) Common genetic polymorphisms affect the human requirement for the nutrient choline. FASEB J. 20, 1336-1344.
8. Kohlmeier, M., da Costa, K. A., Fischer, L. M., and Zeisel, S. H. (2005) Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans. Proc. Natl. Acad. Sci. U. S. A. 102, 16025-16030.
9. Buchman, A. L., Ament, M. E., Sohel, M., Dubin, M., Jenden, D. J., Roch, M., Pownall, H., Farley, W., Awal, M., and Ahn, C. (2001) Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial. J. Parenter. Enteral. Nutr. 25, 260-268.
10. Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y. C., Torbenson, M. S., Unalp-Arida, A., Yeh, M., McCullough, A. J., and Sanyal, A. J. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313- 1321.
11. Barrett, J. C., Fry, B., Maller, J., and Daly, M. J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265.
12. Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., and Haussler, D. (2002) The human genome browser at UCSC. Genome Res. 12, 996-1006.
13. Fan, J. B., Oliphant, A., Shen, R., Kermani, B. G., Garcia, F., Gunderson, K. L., Hansen, M., Steemers, F., Butler, S. L., Deloukas, P., Galver, L., Hunt, S., McBride, C., Bibikova, M., Rubano, T., Chen, J., Wickham, E., Doucet, D., Chang, W., Campbell, D., Zhang, B., Kruglyak, S., Bentley, D., Haas, J., Rigault, P., Zhou, L., Stuelpnagel, J., and Chee, M. S. (2003) Highly parallel SNP genotyping. Cold Spring Harb. Symp. Quant. Biol. 68, 69-78.
14. Jurinke, C., van den Boom, D., Cantor, C. R., and Koster, H. (2002) Automated genotyping using the DNA MassArray technology. Methods Mol. Biol. 187, 179-192.
15. da Costa, K. A., Sanders, L. M., Fischer, L. M., and Zeisel, S. H. (2011) Docosahexaenoic acid in plasma phosphatidylcholine may be a potential marker for in vivo phosphatidylethanolamine N-methyltransferase activity in humans. Am. J. Clin. Nutr. 93, 968-974.
16. Gao, X., Starmer, J., and Martin, E. R. (2008) A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet. Epidemiol. 32, 361-369.
17. Ward, J. H. (1963) Hierarchical grouping to optimize an objective function. J. Am. Stat. Assoc. 58, 236-244 18.
18. Pickett-Blakely, O. E., Huizinga, M. M., and Clark, J. M. (2012) Sociodemographic trends in bariatric surgery utilization in the U. S. A. Obes. Surg. 22, 838-842.
19. Musso, G., Gambino, R., De Michieli, F., Durazzo, M., Pagano, G., and Cassader, M. (2008) Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH. Hepatology 47, 1167-1177.
20. Song, J., da Costa, K. A., Fischer, L. M., Kohlmeier, M., Kwock, L., Wang, S., and Zeisel, S. H. (2005) Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). FASEB J. 19, 1266-1271.
21. Rey, J. W., Noetel, A., Hardt, A., Canbay, A., Alakus, H., Zur Hausen, A., Dienes, H. P., Drebber, U., and Odenthal, M. (2010) Pro12Ala polymorphism of the peroxisome proliferatoractivated receptor gamma2 in patients with fatty liver diseases. World J. Gastroenterol. 16, 5830-5837.
22. Sookoian, S., Castano, G., Gianotti, T. F., Gemma, C., Rosselli, M. S., and Pirola, C. J. (2008) Genetic variants in STAT3 are associated with nonalcoholic fatty liver disease. Cytokine 44, 201-206.
23. Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., and Hobbs, H. H. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387-1395.
24. (2010) A map of human genome variation from populationscale sequencing. Nature 467, 1061-1073.
25. Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., and Hobbs, H. H. (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461-1465.
26. Lehner, B. (2011) Molecular mechanisms of epistasis within and between genes. Trends Genet. 27, 323-331.
27. Guerrerio, A. L., Colvin, R. M., Schwartz, A. K., Molleston, J. P., Murray, K. F., Diehl, A., Mohan, P., Schwimmer, J. B., Lavine, J. E., Torbenson, M. S., and Scheimann, A. O. (2012) Choline intake in a large cohort of patients with nonalcoholic fatty liver disease. Am. J. Clin. Nutr. 95, 892-900.
28. Huang, Y., Cohen, J. C., and Hobbs, H. H. (2011) Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. J. Biol. Chem. 286, 37085-37093.
29. Kumari, M., Schoiswohl, G., Chitraju, C., Paar, M., Cornaciu, I., Rangrez, A. Y., Wongsiriroj, N., Nagy, H. M., Ivanova, P. T., Scott, S. A., Knittelfelder, O., Rechberger, G. N., Birner-Gruenberger, R., Eder, S., Brown, H. A., Haemmerle, G., Oberer, M., Lass, A., Kershaw, E. E., Zimmermann, R., and Zechner, R. (2012) Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase. Cell Metab. 15, 691-702.
30. Yki-Jarvinen, H. (2010) Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data. Curr. Opin. Clin. Nutr. Metab. Care 13, 709-714.
31. Davit-Spraul, A., Gonzales, E., Baussan, C., and Jacquemin, E. (2010) The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. Semin. Liver Dis. 30, 134-146.
32. Hylemon, P. B., Zhou, H., Pandak, W. M., Ren, S., Gil, G., and Dent, P. (2009) Bile acids as regulatory molecules. J. Lipid Res. 50, 1509-1520.
33. Hochrath, K., Krawczyk, M., Goebel, R., Langhirt, M., Rathkolb, B., Micklich, K., Rozman, J., Horsch, M., Beckers, J., Klingenspor, M., Fuchs, H., Gailus-Durner, V., Wolf, E., Acalovschi, M., Volmer, D. A., Hrabe de Angelis, M., and Lammert, F. (2012) The hepatic phosphatidylcholine transporter ABCB4 as modulator of glucose homeostasis. FASEB J. 26, 5081-5091.
34. Kumar, J., Garg, G., Kumar, A., Sundaramoorthy, E., Sanapala, K. R., Ghosh, S., Karthikeyan, G., Ramakrishnan, L., and Sengupta, S. (2009) Single nucleotide polymorphisms in homocysteine metabolism pathway genes: association of CHDH A119C and MTHFR C677T with hyperhomocysteinemia. Circ. Cardiovasc. Genet. 2, 599-606.
35. Lambrinoudaki, I., Kaparos, G., Papadimitriou, D., Sergentanis, T. N., Creatsa, M., Alexandrou, A., Logothetis, E., Christodoulakos, G., and Kouskouni, E. (2008) Methylenetetrahydrofolate reductase C677T polymorphism is associated with central adiposity and increased androgenicity in healthy postmenopausal women. Eur. J. Endocrinol. 159, 233-241.
36. Zeisel, S. H., and da Costa, K. A. (2009) Choline: an essential nutrient for public health. Nutr. Rev. 67, 615-623.
37. Michel, V., and Bakovic, M. (2009) The solute carrier 44A1 is a mitochondrial protein and mediates choline transport. FASEB J. 23, 2749-2758.
38. Petersen, K. F., Dufour, S., Hariri, A., Nelson-Williams, C., Foo, J. N., Zhang, X. M., Dziura, J., Lifton, R. P., and Shulman, G. I. (2010) Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N. Engl. J. Med. 362, 1082-1089.
39. Miller, M., Rhyne, J., Chen, H., Beach, V., Ericson, R., Luthra, K., Dwivedi, M., and Misra, A. (2007) APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome. Arch. Med. Res. 38, 444-451.
40. Lee, H. Y., Birkenfeld, A. L., Jornayvaz, F. R., Jurczak, M. J., Kanda, S., Popov, V., Frederick, D. W., Zhang, D., Guigni, B., Bharadwaj, K. G., Choi, C. S., Goldberg, I. J., Park, J. H., Petersen, K. F., Samuel, V. T., and Shulman, G. I. (2011) Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance. Hepatology 54, 1650-1660.
41. Peter, A., Kantartzis, K., Machicao, F., Machann, J., Wagner, S., Templin, S., Konigsrainer, I., Konigsrainer, A., Schick, F., Fritsche, A., Haring, H. U., and Stefan, N. (2012) Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content. Int. J. Obes. (Lond.) 36, 774-782.
42. Kozlitina, J., Boerwinkle, E., Cohen, J. C., and Hobbs, H. H. (2011) Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance. Hepatology 53, 467-474.
43. Valenti, L., Nobili, V., Al-Serri, A., Rametta, R., Leathart, J. B., Zappa, M. A., Dongiovanni, P., Fracanzani, A. L., Alterio, A., Roviaro, G., Daly, A. K., Fargion, S., and Day, C. P. (2011) The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver. J. Hepatol. 55, 1409-1414.
44. Rizki, G., Arnaboldi, L., Gabrielli, B., Yan, J., Lee, G. S., Ng, R. K., Turner, S. M., Badger, T. M., Pitas, R. E., and Maher, J. J. (2006) Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1. J. Lipid Res. 47, 2280-2290.
45. Warensjo, E., Ingelsson, E., Lundmark, P., Lannfelt, L., Syvanen, A. C., Vessby, B., and Riserus, U. (2007) Polymorphisms in the SCD1 gene: associations with body fat distribution and insulin sensitivity. Obesity (Silver Spring) 15, 1732-1740.
46. Schaeffer, L., Gohlke, H., Muller, M., Heid, I. M., Palmer, L. J., Kompauer, I., Demmelmair, H., Illig, T., Koletzko, B., and Heinrich, J. (2006) Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum. Mol. Genet. 15, 1745-1756.
47. Truong, H., DiBello, J. R., Ruiz-Narvaez, E., Kraft, P., Campos, H., and Baylin, A. (2009) Does genetic variation in the Delta6- desaturase promoter modify the association between alphalinolenic acid and the prevalence of metabolic syndrome? Am. J. Clin. Nutr. 89, 920-925.
48. Speliotes, E. K., Yerges-Armstrong, L. M., Wu, J., Hernaez, R., Kim, L. J., Palmer, C. D., Gudnason, V., Eiriksdottir, G., Garcia, M. E., Launer, L. J., Nalls, M. A., Clark, J. M., Mitchell, B. D., Shuldiner, A. R., Butler, J. L., Tomas, M., Hoffmann, U., Hwang, S. J., Massaro, J. M., O'Donnell, C. J., Sahani, D. V., Salomaa, V., Schadt, E. E., Schwartz, S. M., Siscovick, D. S., Voight, B. F., Carr, J. J., Feitosa, M. F., Harris, T. B., Fox, C. S., Smith, A. V., Kao, W. H., Hirschhorn, J. N., and Borecki, I. B. (2011) Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 7, e1001324.
49. Meigs, J. B., Shrader, P., Sullivan, L. M., McAteer, J. B., Fox, C. S., Dupuis, J., Manning, A. K., Florez, J. C., Wilson, P. W., D'Agostino, R. B., Sr., and Cupples, L. A. (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N. Engl. J. Med. 359, 2208-2219.
50. Kathiresan, S., Melander, O., Anevski, D., Guiducci, C., Burtt, N. P., Roos, C., Hirschhorn, J. N., Berglund, G., Hedblad, B., Groop, L., Altshuler, D. M., Newton-Cheh, C., and Orho- Melander, M. (2008) Polymorphisms associated with cholesterol and risk of cardiovascular events. N. Engl. J. Med. 358, 1240- 1249.
51. Kimm, S. Y., Glynn, N. W., Aston, C. E., Damcott, C. M., Poehlman, E. T., Daniels, S. R., and Ferrell, R. E. (2002) Racial differences in the relation between uncoupling protein genes and resting energy expenditure. Am. J. Clin. Nutr. 75, 714-719.
52. Hung, J., Abratte, C. M., Wang, W., Li, R., Moriarty, D. J., and Caudill, M. A. (2008) Ethnicity and folate influence choline status in young women consuming controlled nutrient intakes. J. Am. Coll. Nutr. 27, 253-259.
53. Field, L. A., Love, B., Deyarmin, B., Hooke, J. A., Shriver, C. D., and Ellsworth, R. E. (2012) Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women. Cancer 118, 1334-1344.
54. Abu Dayyeh, B. K., Yang, M., Fuchs, B. C., Karl, D. L., Yamada, S., Sninsky, J. J., O'Brien, T. R., Dienstag, J. L., Tanabe, K. K., and Chung, R. T. (2011) A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology 141, 141-149.
55. Chen, R., Davydov, E. V., Sirota, M., and Butte, A. J. (2010) Non-synonymous and synonymous coding SNPs show similar likelihood and effect size of human disease association. PLoS One 5, e13574.
56. Chalasani, N., Guo, X., Loomba, R., Goodarzi, M. O., Haritunians, T., Kwon, S., Cui, J., Taylor, K. D., Wilson, L., Cummings, O. W., Chen, Y. D., and Rotter, J. I. (2010) Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology 139, 1567-1576, 1576.e1561-e1566.